| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |